2025 Hematology News

 

November 2025

Mathew Angelos, MD, PhD tests a "Homegrown Treatment," a novel chimeric antigen receptor (CAR) T-cell therapy for an aggressive, difficult to treat leukemia.

 

September 2025

Ron Uecker's B-cell lymphoma got under control in the clinical trial overseen by Manali Kamdar, MD. The trial combines a targeted chemotherapy treatment with a bispecific antibody.

 

August 2025

Lymphoma expert, Manali Kamdar, MD, sees a 'Huge Win for Patients' when barriers for CAR T-Cell treatment are lowered. FDA rule change lowers barriers.

 

June 2025

Eric Pietras, PhD and Brett Stevens, PhD team up on a multi-year search for better ways to target the malignant blood-forming stem cells that give rise to a spectrum of blood cancers called myelodysplastic syndrome (MDS).

 

May 2025

Hematology's Steve Bair, MD, a lymphoma expert, weighs in on alarming recent research suggesting an increased cancer risk among people with tattoos.

 

January 2025

Hematology's Jonathan Gutman, MD, a member of the CU Department of Medicine's  Clinical Excellence Society specializes in stem cell transplants for leukemia and other blood cancer patients.

66th ASH Annual Meeting & Exposition DECEMBER 7 - 10th, 2024

CU Division of Hematology is well represented at the world's most comprehensive hematology event of the year in San Diego, California. For those unfamiliar, the American Society of Hematology (ASH) is the world's largest professional society concerned with the causes and treatments of blood disorders. Approximately 30,000 attendees are expected in 2024.

**We share information. We learn. We collaborate. And when we succeed in discovering improved therapies for blood disorder patient care, the world is a better place.

2024

 

December 2024

Early-career Investigator Aims to Transform Leukemia Treatment with a Novel Approach to CAR T-cell Therapy

 

November 2024

Division of Hematology's Tori Knox-Rice, PhD, receives the Ancora Imparo Award in recognition of her outstanding and inspirational contributions to intern training.

 

October 2024

Division of Hematology's Meredith Beaton, AG-ACNP, MSN, RN takes on new leadership role to promote, develop and elevate the APP faculty experience within University of Colorado Anschutz Medical Campus and UCHealth.  

 

Summer 2024

CU Cancer Center and Division of Hematology's Benjamin Brewer, PsyD, is awarded a $1.55M R25 grant to develop a nationwide training program to help clinicians use the latest digital tools.

 

August 2024

5280 Magazine's Top Doctors of 2024 announced, including Dr. Tyler Buckner, Hematology!

 

June 2024

The 2024 - 2025 PACE Scholars are announced!

As a clinician educator, Hematology's Dr. Lisa Chu is chosen for making crucial contributions towards the success of the University of Colorado's Department of Medicine.


 

April 2024

Presented by VJHemOnc: "The sequencing of CD19-targeting CAR-Ts and CD20-targeting bispecifices in DLBCL"

Want a comprehensive overview of the FDA-approved CD19 #CART products & CD20 bispecifics available for #DLBCL and an insight into their optimal sequencing? Watch the wonderful interview with
@mana1981
(
@CUCancerCenter
): 👉 ow.ly/YNcy50R7mwE

 

March 2024

CU Cancer Center Members Spotlight New Treatments for Relapsed Lymphomas

Manali Kamdar, MD, and Ajay Major, MD, MBA, published an educational review in conjunction with the American Society of Hematology annual meeting.

 

 

January 24. 2024

American Society of Clinical Oncology

HOT OFF THE PRESS 📰 Featured in #ASCODailyNews!! 📸  *Dr. Cassandra Duarte and Dr. Ajay Major* 📸

Understanding the Role of High-Dose Chemotherapy With ASCT Compared With CAR T-Cell Therapies in R/R LBCL

 

 

January 2024

Dr. Manali Kamdar was invited to chair the "How Do We Calibrate Cellular Therapy for Lymphoma in 2023?" Education Session @ the ASH 2023 Annual Meeting in San Diego, California.

She led the panel discussing cellular therapies such as CAR-T and bispecific antibodies. Important:

  • These novel therapies are used to treat aggressive relapsed non-Hodgkin lymphomas.
  • Anschutz Medical Campus is one of the only centers in this region of the United States to offer these novel therapies.
As part of the panel, Dr. Kamdar and Dr. Ajay Major published a review manuscript in Blood, a high impact publication within the field of hematology that often sets the practice patterns for years.

Featured Media | Rocky Mountain Region | Anschutz Medical Campus

Dr. Dan Pollyea

 | 'Possibilities Endless' |


CU Hematology Logo

For appointments,

   for referrals,

      for consultations -

Contact us ~ start here.

Hematology

CU Anschutz

Research Complex II

12700 East 19th Avenue

Mail Stop B170

Aurora, CO 80045

Appointments: 720-848-6400

Directories
Partnerships
Donate
CMS Login